Idiosyncratic drug-induced liver injury (DILI), when severe, can be associated with significant morbidity and mortality. Currently, there are no specific therapies for DILI, apart from corticosteroids for drug-induced autoimmune hepatitis caused by drugs such as nitrofurantoin or minocycline. We present 2 cases of DILI that improved with corticosteroid therapy despite the lack of autoimmune features by serology or histology. The current observations make a strong case for formally testing corticosteroids in a controlled trial in patients with suspected DILI
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
A 33-year-old woman with multiple sclerosis, medicated with high doses of methylprednisolone, cyclop...
Aim: To raise the awareness of general practitioners with special characteristics of the clinical ma...
Autoimmune hepatitis (AIH) was the first liver disease for which an effective therapeutic interventi...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
Introduction: Apart from cessation of the implicated agent leading to drug-induced liver injury (DIL...
Introduction: Apart from cessation of the implicated agent leading to drug-induced liver injury (DIL...
Drug-induced liver injury (DILI) has features similar to those of other liver diseases including aut...
No multi-national prospective study of drug-induced liver injury (DILI) has originated in Europe. Th...
Drug-induced liver injury (DILI) remains the most common cause of acute liver failure (ALF) in the w...
Background Anabolic androgenic steroids (AAS) usage is widespread and increasing. AAS drug-induced l...
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingl...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
We investigated clinical features, therapy, and outcomes of patients hospitalized for drug-induced l...
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingl...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
A 33-year-old woman with multiple sclerosis, medicated with high doses of methylprednisolone, cyclop...
Aim: To raise the awareness of general practitioners with special characteristics of the clinical ma...
Autoimmune hepatitis (AIH) was the first liver disease for which an effective therapeutic interventi...
Drug‐induced liver injury (DILI) is an uncommon but important cause of liver disease that can arise ...
Introduction: Apart from cessation of the implicated agent leading to drug-induced liver injury (DIL...
Introduction: Apart from cessation of the implicated agent leading to drug-induced liver injury (DIL...
Drug-induced liver injury (DILI) has features similar to those of other liver diseases including aut...
No multi-national prospective study of drug-induced liver injury (DILI) has originated in Europe. Th...
Drug-induced liver injury (DILI) remains the most common cause of acute liver failure (ALF) in the w...
Background Anabolic androgenic steroids (AAS) usage is widespread and increasing. AAS drug-induced l...
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingl...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
We investigated clinical features, therapy, and outcomes of patients hospitalized for drug-induced l...
Drug-induced liver injury (DILI) can mimic almost all other liver disorders. A phenotype increasingl...
To access publisher full text version of this article. Please click on the hyperlink in Additional L...
A 33-year-old woman with multiple sclerosis, medicated with high doses of methylprednisolone, cyclop...
Aim: To raise the awareness of general practitioners with special characteristics of the clinical ma...